Using Routine Health Data in FDA Drug Reviews May Raise Oversight

November 28, 2018

The Food and Drug Administration (FDA) is looking into whether the use of routinely collected health data to support drug and device approvals could trigger compliance requirements for protecting research subjects.

Related Stories